Health (PRISME)

  • Presentation
  • Activities
  • Members
  • Publications

The PRISME team is composed of physicists, biochemists, biologists and radiotherapists. We specialize in multidisciplinary research aimed at developing, optimizing and controlling innovative radiotherapies, whether it be hadrontherapy or therapies using radioactive ion-emitting elements or nanoparticles. These radiotherapies aim to improve the treatment of certain cancers by increasing the effect of ionizing radiation in the tumor while minimizing its harmful effects on healthy tissues.

Our multidisciplinary approach aims to quantify, understand and predict the effect of ionizing radiation on living organisms from processes induced at extremely short times (attosecond) at small scales (atomic nucleus) to long-term consequences (years) at the patient level.
We therefore design and carry out irradiation experiments on targets ranging from molecules or cells to small animals and patient samples (tumor, blood). These experiments feed an important part of our activity which consists in modeling the effects of radiation on living organisms.

One of the innovative techniques of radiotherapy is hadrontherapy, which is to send
an ion beam on the tumors to destroy them. We are working, in particular using simulations, data processing and predictions, to improve these systems by having on-line control over irradiation using dedicated detectors. These tools also have applications in imaging.

The activities can be divided into three research areas:

Axis 1 aims to develop simulations and detectors to control patient irradiation by detecting the particles emitted during hadrontherapy treatment. These developments also offer application prospects in the field of diagnostic imaging.

Axis 2 focuses on the development of multi-scale models and simulations to describe and predict the physical, chemical and biological processes induced by irradiation. It also develops irradiation and dosimetric control means for the measurement of radiobiological effects.

Axis 3 quantifies by experiment the effects induced by irradiation with molecular, cellular, multicellular, in-vitro or in-vivo systems. It focuses on the specificities of innovative radiotherapies and the personalization of care.

PERMANENTS:

NON-PERMANENTS:

- DOCTORANTS / DOCTORAL STUDENTS:

- CHERCHEURS NON-PERMANENTS / NON-PERMANENT RESEARCHERS:
8786 documents

  • S. Mariazzi, R. Caravita, A. Vespertini, A. Camper, B. Rienacker, et al.. Techniques for Production and Detection of 2^3S Positronium. 15th International Workshop on Slow Positron Beam Techniques and Applications, Sep 2019, Prague, Czech Republic. pp.91-95, ⟨10.12693/APhysPolA.137.91⟩. ⟨hal-02564659⟩
  • Benedetta Nodari, Gianmario Bergamin, Luigi Caponetto, Alessandro Caratelli, Davide Ceresa, et al.. First results from the CIC data aggregation ASIC for the Phase 2 CMS Outer Tracker. Topical Workshop on Electronics for Particle Physics, Sep 2019, Santiago de Compostela, Spain. pp.102, ⟨10.22323/1.370.0102⟩. ⟨hal-02572520⟩
  • Simone Scarfi, Gianmario Bergamin, Alessandro Caratelli, Luigi Caponetto, Davide Ceresa, et al.. Study of a Triggered, Full Event Zero-Suppressed Front-End Readout Chain operating up to 1 MHz Trigger Rate and Pileup of 300 for CMS Outer Tracker upgrade at HL-LHC. Topical Workshop on Electronics for Particle Physics, Sep 2019, Santiago de Compostela, Spain. pp.012, ⟨10.22323/1.370.0012⟩. ⟨hal-02572513⟩
  • C. Verry, E. Porcel, C. Chargari, C. Rodriguez-Lafrasse, J. Balosso. Utilisation de nanoparticules comme agent radiosensibilisant en radiothérapie : où en est-on ?. Cancer/Radiothérapie, 2019, 23 (8), pp.917-921. ⟨10.1016/j.canrad.2019.07.134⟩. ⟨hal-02309383⟩
  • Dimitrios Tsimpis. Consistent truncation on Calabi-Yau and Nearly-Kähler manifolds. 19th Hellenic School and Workshops on Elementary Particle Physics and Gravity, Aug 2019, Corfu, Greece. pp.122, ⟨10.22323/1.376.0122⟩. ⟨hal-02504614⟩
  • Safa Louati, Anne‐sophie Wozny, Jean-Baptiste Guy, Ladjohounlou Riad, Céline Malésys, et al.. Deciphering the role of stress granules in the cellular response to radiation of HNSCC cancer cells. ICRR 2019, Aug 2019, Manchester, United Kingdom. ⟨hal-02358809⟩
  • Delphine Vernos, P. Rocchi, Marie-Thérèse Aloy, F. Lux, O. Tillement, et al.. Novel generation of ultrasmall high Z tailored nanoparticles for tumor cell radiosensitization. ICRR 2019, Aug 2019, Manchester, United Kingdom. ⟨hal-02358778⟩
  • Anne -Sophie Wozny, Gersende Alphonse, Céline Malesys, Caterina Monini, Philippe Lalle, et al.. Central role of spatial ROS distribution at the nanometric scale in the molecular response to carbon ion irradiation. ICRR 2019, Aug 2019, Manchester, United Kingdom. ⟨hal-02355504⟩
  • C. Rodriguez-Lafrasse, M.-T. Aloy, G. Ollier, Delphine Vernos, Riad Ladjohounlou, et al.. Transfer of the ultrasmall theranostic gadolinium-based nanoparticle AGuIX® to clinical medicine. ICRR 2019, Aug 2019, Manchester, United Kingdom. ⟨hal-02355627⟩
  • Riad Ladjohounlou, Alexandra Lauret, Dominique Ardail, Gersende Alphonse, Claire Rodriguez-Lafrasse. Involvement of ceramide enriched domains in the targeted and non-targeted effects of HNSCC cancer cells. ICRR 2019, Aug 2019, Manchester, United Kingdom. ⟨hal-02358759⟩

Powered by HAL logo